JP2008528696A5 - - Google Patents

Download PDF

Info

Publication number
JP2008528696A5
JP2008528696A5 JP2007554228A JP2007554228A JP2008528696A5 JP 2008528696 A5 JP2008528696 A5 JP 2008528696A5 JP 2007554228 A JP2007554228 A JP 2007554228A JP 2007554228 A JP2007554228 A JP 2007554228A JP 2008528696 A5 JP2008528696 A5 JP 2008528696A5
Authority
JP
Japan
Prior art keywords
lipid
complex
serine
group
therapeutic agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007554228A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008528696A (ja
Filing date
Publication date
Priority claimed from US11/049,134 external-priority patent/US7351688B2/en
Application filed filed Critical
Publication of JP2008528696A publication Critical patent/JP2008528696A/ja
Publication of JP2008528696A5 publication Critical patent/JP2008528696A5/ja
Pending legal-status Critical Current

Links

JP2007554228A 2005-02-02 2006-02-02 低免疫原性のタンパク質製剤のための組成物および方法 Pending JP2008528696A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/049,134 US7351688B2 (en) 2003-02-05 2005-02-02 Compositions and methods for less immunogenic protein formulations
PCT/US2006/003779 WO2006084095A1 (en) 2005-02-02 2006-02-02 Compositions and methods for less immunogenic protein formulations

Publications (2)

Publication Number Publication Date
JP2008528696A JP2008528696A (ja) 2008-07-31
JP2008528696A5 true JP2008528696A5 (https=) 2009-04-02

Family

ID=36777576

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007554228A Pending JP2008528696A (ja) 2005-02-02 2006-02-02 低免疫原性のタンパク質製剤のための組成物および方法

Country Status (7)

Country Link
US (1) US7351688B2 (https=)
EP (1) EP1858532A4 (https=)
JP (1) JP2008528696A (https=)
AU (1) AU2006210609A1 (https=)
CA (1) CA2596280A1 (https=)
NZ (1) NZ560327A (https=)
WO (1) WO2006084095A1 (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007117469A2 (en) 2006-03-30 2007-10-18 The Research Foundation Of State University Of New York Compositions of less immunogenic and long-circulating protein-lipid complexes
EP1988101A1 (en) * 2007-05-04 2008-11-05 Novo Nordisk A/S Improvement of factor VIII polypeptide titers in cell cultures
EP3058953A1 (en) * 2009-07-07 2016-08-24 The Research Foundation Of State University Of New York Lipidic compositions for induction of immune tolerance
US10617640B2 (en) 2009-07-07 2020-04-14 The Research Foundation For The State University Of New York Phosphoserine containing compositions for immune tolerance induction
WO2013070362A1 (en) 2011-10-06 2013-05-16 The Research Foundation Of State University Of New York Compositions and methods for immune tolerance induction
US8951563B2 (en) * 2009-08-06 2015-02-10 Technion Research & Development Foundation Limited Antibiotic drug delivery and potentiation
EP2957628A1 (en) 2010-10-05 2015-12-23 Novo Nordisk Health Care AG Process for protein production
EP2704688B1 (en) * 2011-05-05 2019-07-10 Matinas BioPharma Nanotechnologies, Inc. Cochleate compositions and methods of making and using same
US20160243220A1 (en) * 2013-09-24 2016-08-25 The Research Foundation For The State University Of New York Compositions and methods for reducing antigen-specific immunogenicity
ES2952038T3 (es) * 2016-04-05 2023-10-26 Univ New York State Res Found Composiciones que contienen fosfoserina para la inducción de la tolerancia inmune

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4127502A (en) * 1977-06-10 1978-11-28 Eastman Kodak Company Stabilizers for reconstituted, lyophilized samples
US4795806A (en) * 1987-07-16 1989-01-03 Miles Laboratories, Inc. Phospholipid affinity purification of Factor VIII:C
US5580856A (en) * 1994-07-15 1996-12-03 Prestrelski; Steven J. Formulation of a reconstituted protein, and method and kit for the production thereof
EP0979102A4 (en) * 1997-04-30 2005-11-23 Enzon Inc DETAILED POLYPEPTIDE MODIFIED BY POLYALKYLENE OXIDE
SE513221C2 (sv) * 1998-04-17 2000-07-31 Net Insight Ab Förfarande och anordning för allokering av tidluckor till en kanal i ett kretskopplat tidsmultiplexerat nät
US6593294B1 (en) * 1998-04-27 2003-07-15 Opperbas Holding B.V. Pharmaceutical composition comprising Factor VIII and neutral liposomes
AU2002239607A1 (en) * 2000-11-30 2002-06-11 Baxter Healthcare Corporation Ahf associated dispersion system and method for preparation
ZA200305980B (en) * 2001-02-12 2007-01-31 Res Dev Foundation Modified proteins, designer toxins, and methods of making thereof
WO2003013245A1 (en) * 2001-08-07 2003-02-20 Wisconsin Alumni Research Foundation Polyamines and analogs for protecting cells during cancer chemotherapy and radiotherapy
US20040229793A1 (en) * 2003-02-05 2004-11-18 Balasubramanian Sathyamangalam V. Compositions and methods for less immunogenic protein formulations

Similar Documents

Publication Publication Date Title
Baer et al. New insights into exogenous surfactant as a carrier of pulmonary therapeutics
JP2015519383A5 (https=)
JP2004529163A5 (https=)
JP2018184470A5 (https=)
KR100381449B1 (ko) 에테르지질리포좀과이들의제약학적용도
Dass et al. Apolipoprotein A‐I, cyclodextrins and liposomes as potential drugs for the reversal of atherosclerosis. A review
JP2015515992A5 (https=)
Rakotomanga et al. Hexadecylphosphocholine interaction with lipid monolayers
JP2008528696A5 (https=)
JP2019023243A5 (https=)
JP2016505545A5 (https=)
NL8002097A (nl) Parenteraal toedienbare stabiele geneesmiddel- oplossingen.
HRP20201761T1 (hr) Prilagođeni liposomi za tretman bakterijskih infekcija
US8252836B2 (en) Preparations of phospholipids and pharmaceuticals containing 5-amino salicylic acid for the treatment of inflammatory bowel disease
JP2007515471A5 (https=)
ATE469660T1 (de) Gasgefüllte mikrovesikel mit polymer- modifizierten lipiden
Dynarowicz-Latka et al. Advantages of the classical thermodynamic analysis of single—and multi-component Langmuir monolayers from molecules of biomedical importance—theory and applications
JP2010505937A5 (https=)
Das et al. The influence of lung surfactant liquid crystalline nanostructures on respiratory drug delivery
JP2010507580A5 (https=)
Rouquette et al. Adenosine and lipids: A forced marriage or a love match?
CA2473395A1 (en) Phospholipid bodies and use thereof in medical treatment
JP2008519064A5 (https=)
JP2015511618A (ja) 小胞製剤
FI3954360T3 (fi) Hiilihydraattien lääkevalmiste terapeuttiseen käyttöön